Moderna Works on Vaccines to Get Ahead of Covid-19 Variants

The transcript discusses the efficacy of vaccines against COVID-19, including the potential need for revaccination due to variants. It highlights Moderna's trials for children and the biotech industry's role in developing treatments. The speaker also talks about Flagship Pioneering's innovative approach to creating biotech companies and the importance of leadership in driving these initiatives.

What factors are considered when determining the right dose for younger populations?

How is the biotech industry responding to the COVID-19 pandemic according to the text?

What role does leadership play in developing new technologies in the biotech field?